Goleta medical device maker Inogen wowed investors in early November, after a third quarter that surpassed analyst expectations and a new forecast that put revenue growth back on the double digit track for 2020. The results earned the stock an upgrade from Needham & Co. analyst Mike Matson, and sent shares up 15 percent Nov.…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
